Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cyclophosphamide, Etoposide, and Intermediate-Dose of Carboplatin; An Efficient Preparative Regimen for Autologous Transplantation for Patients with Lymphoma, a Good Alternative to Those Based on Carmustine. Experience with 108 Patients

Giovanni Ruiz, Amado J Karduss, Angela Maria Trujillo, Rosendo Perez, Angelica Cardona, Lina Callejas

Blood (2021) 138 (Supplement 1): 2914.

https://doi.org/10.1182/blood-2021-149816

Published: 2021

Journal Articles

Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 Years

Angela Maria Trujillo, MD, Amado J Karduss, MD, Gloria Suarez, MD, Rosendo Perez, MD, Giovanni Ruiz, MD, Angelica Cardona, tech, Jimenez Alejo, MD, Monica Ramirez, MD, Jose Betancur, MD, Pedro Reyes, MD, Luis R Gomez, MD

Blood (2017) 130 (Supplement 1): 4563.

https://doi.org/10.1182/blood.V130.Suppl_1.4563.4563

Published: 2017

Journal Articles

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Amado J Karduss-Urueta, MD, Rosendo Perez, MD, Gloria Suarez, Alejo Jimenez, MD, Giovanni Ruiz, MD, Angela Maria Trujillo, MD, Monica Ramirez, Jose Betancur, MD, Pedro Reyes, MD, Luis Rodolfo Gomez, MD, Angelica Cardona

Blood (2016) 128 (22): 2192.

https://doi.org/10.1182/blood.V128.22.2192.2192

Published: 2016

Journal Articles

Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity Conditioning

Amado J Karduss-Urueta, MD, Suarez Gloria, MD, Gonzalez Miguel, MD, Perez Rosendo, MD, Pedro Reyes, MD, Alejo Jimenez, MD, Luis R Gomez, MD, Angelica M Cardona, Tech, Jose Betancur, MD, Monica Ramirez, MD, Giovanni Ruiz, MD

Blood (2015) 126 (23): 3118.

https://doi.org/10.1182/blood.V126.23.3118.3118

Published: 2015

Journal Articles

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Amado J Karduss-Urueta, MD, Giovanni Ruiz, MD, Rosendo Perez, Alejo Jimenez, MD, Angelica Cardona, Tech, Gloria Suarez, MD, Luis R Gomez, MD, Pedro Reyes, MD

Blood (2015) 126 (23): 1916.

https://doi.org/10.1182/blood.V126.23.1916.1916

Published: 2015

NARROW

Cyclophosphamide, Etoposide, and Intermediate-Dose of Carboplatin; An Efficient Preparative Regimen for Autologous Transplantation for Patients with Lymphoma, a Good Alternative to Those Based on Carmustine. Experience with 108 Patients

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity Conditioning

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Email alerts

ASH Publications

American Society of Hematology

Cyclophosphamide, Etoposide, and Intermediate-Dose of Carboplatin; An Efficient Preparative Regimen for Autologous Transplantation for Patients with Lymphoma, a Good Alternative to Those Based on Carmustine. Experience with 108 Patients

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity Conditioning

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only